In MS brain autopsy tissue, CCL2 expression colocalizes with microglia/macrophages and with hypertrophic astrocytes in demyelinated lesions, identifying two possible CNS sources of CCL2 that may be responding to MSC-NP injections [41, 42]. The gene discussed is CCL2; the disease is myeloid sarcoma.